Pemphigus VulgarisSymptoms, Doctors, Treatments, Advances & More
Pemphigus Vulgaris Overview
Learn About Pemphigus Vulgaris
Pemphigus vulgaris (PV) is an autoimmune disorder of the skin. It involves blistering and sores (erosions) of the skin and mucous membranes.
PV
The immune system produces antibodies against specific proteins in the skin and mucous membranes. These antibodies break the bonds between skin cells. This leads to the formation of a blister. The exact cause is unknown.
In rare cases, PV is caused by some medicines, including:
- A medicine called penicillamine, which removes certain materials from the blood (chelating agent)
- Blood pressure medicines called ACE inhibitors
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
PV is uncommon. It most often occurs in middle-aged or older people.
About 50% to 70% of people with this condition first develop painful blisters and sores in the mouth. This is followed by skin blisters. Skin sores may come and go.
The skin sores may be described as:
- Draining
- Oozing
- Crusting
- Peeling or easily detached
They may be located:
- In the mouth and down the throat
- On the face or in the eyes
- On the scalp, trunk, or other skin areas
Severe cases of PV may need wound management, similar to the treatment for severe burns. People with PV may need to stay in a hospital and receive care in a burn unit or intensive care unit.
Treatment is aimed at reducing symptoms, including pain. It also aims to prevent complications, especially infections.
Treatment may involve:
- Antibiotics and antifungal medicines to control or prevent infections
- Fluids and electrolytes given through a vein (IV) if there are severe mouth ulcers
- IV feedings if there are severe mouth ulcers
- Numbing (anesthetic) mouth lozenges to reduce mouth ulcer pain
- Pain medicines if local pain relief is not enough
Body-wide (systemic) therapy is needed to control PV and should be started as early as possible. Systemic treatment includes:
- Medicines that suppress the immune system. These are often first-line treatments (such as rituximab, azathioprine, methotrexate, cyclosporine, cyclophosphamide, or mycophenolate mofetil).
- An anti-inflammatory medicine called dapsone.
- Corticosteroids.
- Medicines containing gold (rarely used now).
Intravenous immunoglobulin (IVIg) is occasionally used.
Plasmapheresis may be used along with systemic medicines to reduce the amount of antibodies in the blood. Plasmapheresis is a process in which antibody-containing plasma is removed from the blood and replaced with intravenous fluids or donated plasma.
Ulcer and blister treatments include soothing or drying lotions, wet dressings, or similar measures.
UCI Health Dermatology Center
Sergei Grando is a Dermatologist practicing medicine in Irvine, California. Dr. Grando is rated as an Elite provider by MediFind in the treatment of Pemphigus Vulgaris. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid. Dr. Grando is board certified in American Board Of Dermatology - Dermatology. Dr. Grando is currently accepting new patients.
Emory Clinic At 1525 Clifton Road
Ron Feldman is a Dermatologist practicing medicine in Atlanta, Georgia. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Pemphigus Vulgaris. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Bullous Pemphigoid, Pemphigus Foliaceus, Pemphigus, and Pemphigus Vulgaris. Dr. Feldman is board certified in American Board Of Dermatology, 2010. Dr. Feldman is currently accepting new patients.
Rush University Medical Center
Kyle Amber is a Dermatologist practicing medicine in Chicago, Illinois. Dr. Amber is rated as an Elite provider by MediFind in the treatment of Pemphigus Vulgaris. He is also highly rated in 91 other conditions, according to our data. His clinical expertise encompasses Bullous Pemphigoid, Pemphigus, Pemphigus Vulgaris, and Cicatricial Pemphigoid. Dr. Amber is currently accepting new patients.
Without treatment, this condition can be life threatening. Severe infection is the most frequent cause of death.
With treatment, the disorder tends to be chronic. Side effects of treatment may be severe or disabling.
Complications of PV include:
- Secondary skin infections
- Severe dehydration
- Side effects of medicines
- Spread of infection through the bloodstream (sepsis)
Your health care provider should examine any unexplained blisters.
Contact your provider if you have been treated for PV and you develop any of the following symptoms:
- Chills
- Fever
- General ill feeling
- Joint aches
- Muscle aches
- New blisters or ulcers
Summary: This is an investigator-initiated, single-center, single-arm, open-label exploratory clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of autologous CD19 CAR-T cell therapy in patients with refractory pemphigus vulgaris.
Summary: Pemphigus vulgaris (PV) is a chronic, potentially life-threatening autoimmune mucocutaneous disorder that significantly impairs patients' quality of life. While systemic corticosteroids and immunosuppressants remain the standard of care, many patients suffer from persistent, painful oral lesions that exhibit delayed healing or poor response to conventional systemic protocols. This clinical trial i...
Published Date: April 09, 2026
Published By: Elika Hoss, MD, Assistant Professor of Dermatology, Mayo Clinic, Scottsdale, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Amagai M. Pemphigus. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 5th ed. Philadelphia, PA: Elsevier; 2025:chap 29.
Dinulos JGH. Vesicular and bullous diseases. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 16.
James WD. Chronic blistering dermatoses. In: James WD, ed. Andrew's Diseases of the Skin: Clinical Dermatology. 14th ed. Philadelphia, PA: Elsevier; 2026:chap 16.

